Gastrointestinal complaints are among the most common in medical care. This comprehensive profile helps pinpoint the causes of gastrointestinal symptoms and chronic systemic conditions, and measures key markers of digestion, absorption and inflammation. Using growth-based culture, the standard of practice in clinical microbiology, as well as sensitive biochemical assays and microscopy, this thorough profile evaluates the status of beneficial and pathogenic microorganisms including aerobic and anaerobic bacteria, yeast and parasites. Antimicrobial susceptibility testing to prescriptive and natural agents is also performed for appropriate bacterial and fungal species at no additional charge.
+ H Pylori This microorganism, which can be found on the stomach mucosa of infected people, causes very frequent and mostly silent infections that can produce gastritis, gastric ulcers and other serious pathologies. This FDA-cleared, non-invasive test directly measures the antigen in stool (not antibodies) and is used for diagnosing Helicobacter pylori infections. It is also used for monitoring therapeutic efficacy during and after treatment.
This order combines the CMI04 and CMI20 Laboratory tests, for Comp Stool with Parasitology and H Pylori.